In patients with type 2 diabetes, compliance and persistence were generally low for both statin and antihyperglycemic therapy, but they were significantly lower with statin therapy.
HMOs in California, particularly Kaiser, have developed approaches to end-of-life care that allow them to use far fewer inpatient resources than fee-for-service providers.
Healthcare professionals report pain management barriers across system, provider, and patient levels, highlighting the need to consider chronic pain as a chronic condition that warrants coordinated approaches.
Low-income rural residents receiving hypertension drugs at no charge had enhanced medication adherence and reduced medical costs in China.
We observed small-area variation in computed tomography scan use for inpatients in New York State, even after controlling for relevant patient and hospital characteristics.
Improving adherence to long-term medication therapy remains a challenge. Health information technology interventions that leverage electronic medical records are promising, low-cost approaches for increasing adherence.
Significant clinically meaningful improvements in asthma impairment are documented by administrative data for 1 year after initiation of step-up care in patients with uncontrolled asthma.
Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL.
Understanding the relationships among patient-reported outcomes, satisfaction, and quality is the first step in drawing meaningful conclusions that can then be translated into policy.
This case study from the MS Center of Saint Louis examines how patients are impacted by high healthcare costs and addresses potential solutions to this problem.
Inappropriate prescribing practices of opioids are a major risk factor for mortality among opioid users in the Georgia Medicaid population, although risk is lower in managed Medicaid.
An analysis of the largest cohort available reveals that youths with type 1 diabetes, on a Medicaid managed care plan, are less likely to be readmitted within 90 days of discharge.
The authors draw on the experience of past and present payment reforms to suggest principles for successfully designing alternative payment models.
A 12-month evaluation of a patient-centered medical home demonstration indicated improvement in quality of care without an increase in overall costs.
Substantive outcome improvement and savings to Medicaid may be achieved with small changes in prescribing rates or comorbidity prevalence among patients with heart failure.